Risk Taker and Entrepreneur Dr. Scott Rocklage

Scott Rocklage is the Founding Partner at 5AM Venture Management, based in the Boston, MA area as soon as the new year began in 2018.

Four years before, Rocklage had the position of being Managing Partner there, before the venture started in 2013. Learn more about Scott Rocklage: http://medicaldailytimes.com/medical-research/scott-rocklage-leading-way-cure/3159/ and https://www.dialdish.com/scott-rocklage-seeks-to-conquer-cancer-by-targeting-mutant-rna-molecules/

When it comes to the healthcare management industry, he has over 20 years experience leading to the success approval of Cubicin, Teslascan, and Omniscan, which are three U.S. New Drug Applications by the FDA, while also entering six other drug candidates into clinical trials, to have the possibility of the drugs being approved by the FDA.

Dr. Rocklage studied at the University of California, Berkeley receiving his B.S. in chemistry, and at the Massachusetts Institute of Technology.

He constantly works with business executives, physicians, scientists, and other entrepreneurs to lead them on the right path to find innovative ideas regarding meeting medical needs, and showing them how their medicine can have a potential of being approved as well.  Read more: Scott Rocklage | Bloomberg and Scott Rocklage | Crunchbase

With the way trends are having a direct impact on the American people today, Dr. Rocklage takes advantage of that fact by learning how to bring new developments to the forefront in the long-run.

Some important factors he has used in his career that has been key, is the understanding that measured risk-taking is involved if you want become successful as an entrepreneur, and by having the most qualified candidates at your place of business is crucial to the character, and well-being of the company.

Rocklage has invented, and co-invented over 30 U.S. patents, making him a major success in the healthcare management field.

Leave a Reply

Your email address will not be published. Required fields are marked *